NCT06027892View on ClinicalTrials.gov

Two-fraction Versus Five-fraction Stereotactic Radiotherapy for Localized Prostate Cancer

NARecruitingINTERVENTIONAL
Enrollment

562

Participants

Timeline

Start Date

December 29, 2022

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2032

Conditions
PROSTATE CANCER
Interventions
RADIATION

Two-fraction stereotactic radiotherapy

Definitive prostate radiotherapy will be delivered to a dose biologically comparable to 40 Gy in 5 treatments, but in only 2 treatments

RADIATION

Five-fraction stereotactic radiotherapy

Definitive prostate radiotherapy will be delivered to a standard stereotactic dose of 40 Gy in 5 treatments

Trial Locations (1)

49100

RECRUITING

Davidoff Cancer Center, Rabin Medical Center, Petah Tikva

All Listed Sponsors
lead

Rabin Medical Center

OTHER